Effect of fish oil on pregnancy outcomes

Clinical trial to evaluate the effect of fish oil supplementation on pregnancy outcomes in pregnant women

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015072123269N1

Enrollment

360

Registered

2017-06-11

Start date

2015-12-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: pre-eclampsia. Condition 2: eclampsia. Condition 3: gestational diabets mellitus. Condition 4: preterm laber. Pre-eclampsia, unspecified Eclampsia in pregnancy Diabetes mellitus in pregnancy, unspecified Preterm spontaneous labour with preterm delivery

Interventions

Intervention group: they will receive Fish oil 1000 mg capsules, one daily since 16-20 gestational weeks until the end of pregnancy

Intervention 1: Intervention group: they will receive Fish oil 1000 mg capsules, one daily since 16-20 gestational weeks until the end of pregnancy. Intervention 2: Control group: they don't receive a

Treatment - Drugs

Control group: they don't receive any medication

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant women aged between 18-35 years old; singleton pregnancy; being in 16th -20th weeks of gestational age; lack of preterm labor history; lack of infertility history. Exclusion criteria: BMI>30; sensivity to fish and fish oil; being smoker or addict.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Lenght of pregnancy. Timepoint: delivery. Method of measurement: week.;Preterm laber. Timepoint: child brith. Method of measurement: week.;Gestational diabets mellitus. Timepoint: 24-28 week. Method of measurement: laboratory test.;Newborn weight. Timepoint: child birth. Method of measurement: by means of newborn scale / gram.;Pre-eclampsia. Timepoint: after 20 week of pregnancy until child birth. Method of measurement: Blood pressure measurment and evaluation of proteinuria.;Eclampsia. Timepoint: seizure. Method of measurement: clinical signs.	—

Measure

Time frame

Lenght of pregnancy. Timepoint: delivery. Method of measurement: week.;Preterm laber. Timepoint: child brith. Method of measurement: week.;Gestational diabets mellitus. Timepoint: 24-28 week. Method of measurement: laboratory test.;Newborn weight. Timepoint: child birth. Method of measurement: by means of newborn scale / gram.;Pre-eclampsia. Timepoint: after 20 week of pregnancy until child birth. Method of measurement: Blood pressure measurment and evaluation of proteinuria.;Eclampsia. Timepoint: seizure. Method of measurement: clinical signs.

—

Secondary

Measure	Time frame
BMI. Timepoint: before pregnancy. Method of measurement: using measurement of height and weight.;Age. Timepoint: at initiation of the study. Method of measurement: year.;Education. Timepoint: at initiation of the study. Method of measurement: question and answer.;Parity. Timepoint: at initiation of the study. Method of measurement: the number of pregnancy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyede Nazanin Gholami

Qazvin University of Medical Sciences

researchdpt@qums.ac.ir+98 28 3333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026